Literature DB >> 11157657

Antithrombotic therapy in patients undergoing percutaneous coronary intervention.

J J Popma1, E M Ohman, J Weitz, A M Lincoff, R A Harrington, P Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11157657     DOI： 10.1378/chest.119.1_suppl.321s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  13 in total

Review 1.  Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes.

Authors:  E R Bates
Journal:  Curr Cardiol Rep       Date:  2001-09       Impact factor: 2.931

2.  Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis.

Authors:  Paola Sanchez-Pena; Jean-Sébastien Hulot; Saïk Urien; Annick Ankri; Jean-Philippe Collet; Rémi Choussat; Philippe Lechat; Gilles Montalescot
Journal:  Br J Clin Pharmacol       Date:  2005-10       Impact factor: 4.335

3.  Study for determination of the optimal cessation period of therapy with anti-platelet agents prior to invasive endoscopic procedures.

Authors:  Tomoko Komatsu; Yoshiko Tamai; Hideki Takami; Kazufumi Yamagata; Shinsaku Fukuda; Akihiro Munakata
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

Review 4.  Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.

Authors:  Monique P Curran; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Use of antiplatelet inhibitors in peripheral vascular interventions.

Authors:  S William Stavropoulos; Richard D Shlansky-Goldberg
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

6.  Heparin in interventional radiology: a therapy in evolution.

Authors:  Stuart B Resnick; Stephanie H Resnick; Joshua L Weintraub; Nishita Kothary
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

7.  Eptifibatide: The evidence for its role in the management of acute coronary syndromes.

Authors:  Ibrahim Shah; Shakeel O Khan; Surender Malhotra; Tim Fischell
Journal:  Core Evid       Date:  2010-06-15

Review 8.  Modulating thrombotic potential in catheter-based percutaneous coronary and peripheral vascular interventions.

Authors:  James L Orford; Peter B Berger
Journal:  J Thromb Thrombolysis       Date:  2004-02       Impact factor: 2.300

Review 9.  Unfractionated versus fractionated heparin for percutaneous coronary intervention.

Authors:  Heidar Arjomand; Satish K Surabhi; Marc Cohen
Journal:  Curr Cardiol Rep       Date:  2002-07       Impact factor: 2.931

Review 10.  Eptifibatide: a pharmacoeconomic review of its use in percutaneous coronary intervention and acute coronary syndromes.

Authors:  Greg L Plosker; Tim Ibbotson
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.